Who makes E. coli strain E1392-75-2A dose 1E8 CFU?

E. coli strain E1392-75-2A dose 1E8 CFU is developed by NIZO Food Research.

What development phase is E. coli strain E1392-75-2A dose 1E8 CFU in?

E. coli strain E1392-75-2A dose 1E8 CFU is in Phase 1.

Last reviewed 2026-05-14 · How we verify

E. coli strain E1392-75-2A dose 1E8 CFU

NIZO Food Research · Phase 1 active Biologic Quality 0/100

At a glance

Generic name	E. coli strain E1392-75-2A dose 1E8 CFU
Sponsor	NIZO Food Research
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

E. coli strain E1392-75-2A dose 1E8 CFU CI brief — competitive landscape report
E. coli strain E1392-75-2A dose 1E8 CFU updates RSS · CI watch RSS
NIZO Food Research portfolio CI